Several studies indicate that changes in AS of the FPGS gene (exon skipping or intron retention) constitute MTX resistance mechanisms in T-ALL where exon 12 is skipped [198], and in childhood ALL (both B- and T-cell) where intron 8 is partially retained [199]. The gene discussed is FPGS; the disease is acute lymphoblastic leukemia.